Adaptive Biotechnologies
Adding Roles, last update 1 week ago
Headquarters Seattle, United States
Everything we hold on Adaptive Biotechnologies, newest first. Every line links to the filing or report it came from.
This profile is thin because we hold 2 source documents on Adaptive Biotechnologies so far, not because nothing else has happened there. We only publish what we have read on a primary source and can link to. So a profile fills up as filings and reports come in, and we never seed it from an estimate. We keep profiles at this stage out of our sitemap and mark them noindex until they carry enough to be worth a search result of their own.
- 2026-08-07Adding Roles Growing and expanding
Adaptive Biotechnologies opened 5 more roles in Seattle (job board: 11 to 16)
A board that grows week on week is the earliest public evidence of hiring intent an employer produces: it moves before any announcement and before any filing. Treat the direction as the signal and the exact count as approximate, since roles are reposted, split across locations and withdrawn without notice.
- 2025-12-31Pay Change Pay and benefits
Adaptive Biotechnologies Corporation: $9,081,690 total compensation for the principal executive officer, fiscal year ended 2025-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2024-12-31Pay Change Pay and benefits
Adaptive Biotechnologies Corporation: $4,973,301 total compensation for the principal executive officer, fiscal year ended 2024-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2023-12-31Pay Change Pay and benefits
Adaptive Biotechnologies Corporation: $8,904,267 total compensation for the principal executive officer, fiscal year ended 2023-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2022-12-31Pay Change Pay and benefits
Adaptive Biotechnologies Corporation: $8,853,328 total compensation for the principal executive officer, fiscal year ended 2022-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker